Top

Published in:

01-06-2013

Ductal carcinoma in situ (DCIS): posttreatment follow-up care among Latina and non-Latina White women

Authors: Mónica E. López, Celia P. Kaplan, Anna M. Nápoles, Jennifer C. Livaudais, E. Shelley Hwang, Susan L. Stewart, Joan Bloom, Leah Karliner

Published in: Journal of Cancer Survivorship | Issue 2/2013

Abstract

Background

There is a lack of information about posttreatment care among patients with ductal carcinoma in situ (DCIS). This study compares posttreatment care by ethnicity–language and physician specialty among Latina and White women with DCIS.

Methods

Latina and White women diagnosed with DCIS between 2002 and 2005 identified through the California Cancer Registry completed a telephone survey in 2006. Main outcomes were breast surveillance, lifestyle counseling, and follow-up physician specialty.

Key results

Of 742 women (396 White, 349 Latinas), most (90 %) had at least one clinical breast exam (CBE). Among women treated with breast-conserving surgery (BCS; N = 503), 76 % had received at least two mammograms. While 92 % of all women had follow-up with a breast specialist, Spanish-speaking Latinas had the lowest specialist follow-up rates (84 %) of all groups. Lifestyle counseling was low with only 53 % discussing exercise, 43 % weight, and 31 % alcohol in relation to their DCIS. In multivariable analysis, Spanish-speaking Latinas with BCS had lower odds of receiving the recommended mammography screening in the year following treatment compared to Whites (OR 0.5; 95 % CI, 0.2–0.9). Regardless of ethnicity–language, seeing both a specialist and primary care physician increased the odds of mammography screening and CBE (OR 1.6; 95 % CI, 1.2–2.3 and OR 1.9; 95 % CI, 1.3–2.8), as well as having discussions about exercise, weight, and alcohol use, compared to seeing a specialist only.

Conclusions

Most women reported appropriate surveillance after DCIS treatment. However, our results suggest less adequate follow-up for Spanish-speaking Latinas, possibly due to language barriers or insurance access.

Implications for Cancer Survivors

Follow-up with a primary care provider in addition to a breast specialist increases receipt of appropriate follow-up for all women.

Leonard GD, Swain SM. Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst. 2004;96(12):906–20.PubMedCrossRef

Virnig BA, et al. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010;102(3):170–8.PubMedCrossRef

Morrow M, et al. Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin. 2002;52(5):256–76.PubMedCrossRef

Kerlikowske K, et al. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J Natl Cancer Inst. 2003;95(22):1692–702.PubMedCrossRef

Wang SY, et al. Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Breast Cancer Res Treat. 2011;127(1):1–14.PubMedCrossRef

Kane RL, et al. The impact of surgery, radiation, and systemic treatment on outcomes in patients with ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010;2010(41):130–3.PubMedCrossRef

Claus EB, et al. The risk of a contralateral breast cancer among women diagnosed with ductal and. Breast. 2003;12:451–6.PubMedCrossRef

Li CI, et al. Risk of invaive breast carcinoma among women diagnosed wth ductal carcinoma in situ and lobular carcinoma in situ, 1988–2001. Cancer. 2006;106:2104–12.PubMedCrossRef

Innos K, Horn-Ross PL. Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2008;111(3):531–40.PubMedCrossRef

10.

Khatcheressian JL, et al. American society of clinical oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24(31):5091–7.PubMedCrossRef

11.

National Comprehensive Cancer Network. NCCN clinical guidelines in oncology: breast cancer May 5, 2012; Available from: http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed 19 Aug 2012

12.

George SM, et al. Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancer. Cancer Causes Control. 2011;22(4):589–98.PubMedCrossRef

13.

Bertram LA, et al. Physical activity, additional breast cancer events, and mortality among early-stage breast cancer survivors: findings from the WHEL Study. Cancer Causes Control. 2011;22(3):427–35.PubMedCrossRef

14.

Sternfeld B, et al. Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study. Cancer Epidemiol Biomarkers Prev. 2009;18(1):87–95.PubMedCrossRef

15.

Kwan ML, et al. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010;28(29):4410–6.PubMedCrossRef

16.

Holmes MD, et al. Physical activity and survival after breast cancer diagnosis. JAMA. 2005;293(20):2479–86.PubMedCrossRef

17.

Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol. 2002;20(4):1128–43.PubMedCrossRef

18.

Li CI, et al. Epidemiologic and molecular risk factors for contralateral breast cancer among young women. Br J Cancer. 2003;89(3):513–8.PubMedCrossRef

19.

Nekhlyudov L, et al. Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery. J Clin Oncol. 2009;27(19):3211–6.PubMedCrossRef

20.

Kagay CR, Quale C, Smith-Bindman R. Screening mammography in the American elderly. Am J Prev Med. 2006;31(2):142–9.PubMedCrossRef

21.

Wells KJ, Roetzheim RG. Health disparities in receipt of screening mammography in Latinas: a critical review of recent literature. Cancer Control. 2007;14(4):369–79.PubMed

22.

Whitman S, et al. Mammography screening in six diverse communities in Chicago—a population study. Cancer Detect Prev. 2007;31:166–72.PubMedCrossRef

23.

González P, Borrayo EA. The role of physician involvement in Latinas’ mammography screening adherence. Women’s Health Issues. 2010;21(2):165–70.CrossRef

24.

Smith-Bindman R, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med. 2006;144(8):541–53.PubMed

25.

Mack KP, et al. Adherence to recent screening mammography among Latinas: findings from the California Women’s Health Survey. J Womens Health (Larchmt). 2009;18(3):347–54.CrossRef

26.

Hollowell K, et al. American society of clinical oncology-recommended surveillance and physician specialty among long-term breast cancer survivors. Cancer. 2010;116(9):2090–8.PubMed

27.

Kaplan CP, et al. Selection of treatment among Latina and non-Latina White women with ductal carcinoma in situ. J Womens Health (Larchmt). 2011;20(2):215–23.CrossRef

28.

Sangha O, et al. The self-administered comorbidity questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49(2):156–63.PubMedCrossRef

29.

Cummings SR, et al. Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst. 2009;101(6):384–98.PubMedCrossRef

30.

Willett WC, et al. Moderate alcohol consumption and the risk of breast cancer. N Engl J Med. 1987;316(19):1174–80.PubMedCrossRef

31.

Feigelson HS, et al. Alcohol consumption increases the risk of fatal breast cancer (United States). Cancer Causes Control. 2001;12(10):895–902.PubMedCrossRef

32.

Field TS, et al. Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med. 2008;23(2):158–63.PubMedCrossRef

33.

Ganz PA, Hahn EE. Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol. 2008;26(5):759–67.PubMedCrossRef

Title: Ductal carcinoma in situ (DCIS): posttreatment follow-up care among Latina and non-Latina White women
Authors: Mónica E. López
Celia P. Kaplan
Anna M. Nápoles
Jennifer C. Livaudais
E. Shelley Hwang
Susan L. Stewart
Joan Bloom
Leah Karliner
Publication date: 01-06-2013
Publisher: Springer US
Published in: Journal of Cancer Survivorship / Issue 2/2013
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-012-0262-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Key results

Conclusions

Implications for Cancer Survivors

Please log in to get access to this content

Other articles of this Issue 2/2013

Investigating efficacy of two brief mind–body intervention programs for managing sleep disturbance in cancer survivors: a pilot randomized controlled trial

Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care?

Long-term breast cancer survivors’ symptoms and morbidity: differences by sexual orientation?

Employment outcomes among survivors of common cancers: the Symptom Outcomes and Practice Patterns (SOAPP) study

The association between television watching time and all-cause mortality after breast cancer

Physical exercise and return to work: cancer survivors’ experiences

Keynote webinar | Spotlight on antibody–drug conjugates in cancer